#37 – Colin Weller, VP & GM Evidence Platform at Medable
Slice of Healthcare Team
Apr 17, 2024
Details
In This Episode We Discuss: Clinical Trial Innovation
Join us on the latest episode! Our Guest: Colin Weller, VP & GM of Evidence Platform at Medable.
What you'll get out of this episode:
- Introduction of Colin Weller: Vice President and GM of Evidence Platform at Medable, Colin Weller discusses his role in advancing clinical research technology to streamline drug approvals.
- Challenges in Drug Development: Weller details the stagnant pace of drug development, highlighting the industry's need for innovation to improve efficiency and reduce costs.
- Medable's Ambitious Goals: Aiming to increase the number of drugs approved annually by tenfold through advanced SAS technology and AI, setting a new industry standard.
- Innovations in Clinical Trials: Medable has already cut study startup times by 50%, utilizing AI and automation to overhaul traditional processes.
- Future of Digital Clinical Trials: Weller predicts significant advancements in decentralized and digital trials, enhancing patient accessibility and data quality.
Watch
Listen
-2e14ed90-63f5-4ce1-84fc-3fa9506b84be.png&w=3840&q=75)
